Organon & Co. (OGN)
13.89
+0.04
(+0.29%)
USD |
NYSE |
Nov 10, 16:00
13.88
0.00 (0.00%)
After-Hours: 20:00
Organon Price : 13.89 for Nov. 10, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 10, 2026 | 13.83 | 13.89 | 13.83 | 13.89 | 2.356M |
| Nov 09, 2026 | 13.87 | 13.88 | 13.82 | 13.85 | 2.985M |
| Nov 06, 2026 | 13.80 | 13.87 | 13.78 | 13.87 | 3.947M |
| Nov 05, 2026 | 13.86 | 13.86 | 13.79 | 13.79 | 3.756M |
| Nov 04, 2026 | 13.83 | 13.88 | 13.83 | 13.83 | 2.648M |
| Nov 03, 2026 | 13.83 | 13.85 | 13.82 | 13.85 | 3.658M |
| Nov 02, 2026 | 13.85 | 13.85 | 13.82 | 13.82 | 2.147M |
| Oct 30, 2026 | 13.83 | 13.84 | 13.80 | 13.84 | 1.848M |
| Oct 29, 2026 | 13.76 | 13.83 | 13.76 | 13.81 | 2.510M |
| Oct 28, 2026 | 13.75 | 13.78 | 13.75 | 13.78 | 3.163M |
| Oct 27, 2026 | 13.74 | 13.78 | 13.74 | 13.75 | 1.865M |
| Oct 26, 2026 | 13.75 | 13.76 | 13.74 | 13.74 | 1.548M |
| Oct 23, 2026 | 13.74 | 13.76 | 13.74 | 13.75 | 1.054M |
| Oct 22, 2026 | 13.75 | 13.76 | 13.74 | 13.75 | 2.554M |
| Oct 21, 2026 | 13.75 | 13.77 | 13.74 | 13.75 | 2.556M |
| Oct 20, 2026 | 13.75 | 13.80 | 13.74 | 13.76 | 2.550M |
| Oct 19, 2026 | 13.77 | 13.77 | 13.72 | 13.75 | 3.254M |
| Oct 16, 2026 | 13.77 | 13.78 | 13.74 | 13.76 | 2.647M |
| Oct 15, 2026 | 13.75 | 13.77 | 13.75 | 13.76 | 1.980M |
| Oct 14, 2026 | 13.77 | 13.77 | 13.74 | 13.74 | 1.808M |
| Oct 13, 2026 | 13.77 | 13.79 | 13.76 | 13.77 | 2.893M |
| Oct 12, 2026 | 13.80 | 13.80 | 13.76 | 13.77 | 932352.0 |
| Oct 09, 2026 | 13.76 | 13.83 | 13.75 | 13.81 | 3.265M |
| Oct 08, 2026 | 13.78 | 13.80 | 13.75 | 13.75 | 2.090M |
| Oct 07, 2026 | 13.72 | 13.79 | 13.72 | 13.79 | 2.208M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Viatris, Inc. | 20.85 |
| Pacira Biosciences, Inc. | 36.49 |
| Bristol Myers Squibb Co. | 62.80 |
| ANI Pharmaceuticals, Inc. | 71.25 |
| Corcept Therapeutics, Inc. | 73.35 |
Price Related Metrics
| PE Ratio | 18.06 |
| PS Ratio | 0.6069 |
| Price to Book Value | 3.058 |
| Price to Free Cash Flow | 5.036 |
| Earnings Yield | 5.54% |
| Market Cap | 3.648B |
| Operating PE Ratio | 3.095 |
| Normalized PE Ratio | 9.564 |